Participate in multiple sclerosis clinical, rehabilitation, and wellness trials

At Shepherd Center, our multiple sclerosis (MS) research program focuses on improving clinical outcomes and enhancing the quality of life for individuals with MS. We conduct a range of clinical trials and rehabilitation and wellness intervention studies. Our commitment to scientifically sound methods and participant safety helps advance the field of rehabilitation medicine.

About our multiple sclerosis research program

Since 2012, our research has supported the MS clinical program through the Eula C. and Andrew C. Carlos MS Rehabilitation and Wellness Program. Our mission is to improve function, health, wellness, and quality of life for people with MS, especially those facing mobility challenges or limited access to rehabilitation.

Our research explores the impact of both physical and cognitive rehabilitation interventions. We also study how these interventions affect vocational outcomes and overall quality of life. By disseminating our findings to patients, healthcare providers, caregivers, and payers, we aim to optimize care for those living with MS.

Current MS trials seeking participants

Do you qualify to be an MS trial research participant? See the list below to learn more about the current multiple sclerosis clinical trials and studies at Shepherd Center.

Purpose of trial

This study is being done for patients who have a diagnosis of Primary or Secondary Progressive Multiple Sclerosis. The purpose of this study is to assess the effects of an investigational product called IMU-838, a tablet containing vidofludimus calcium, on disease activity and to assess safety.

Participation eligibility

  • Be between the ages of 18 and 65.
  • Be stable with no relapses for the past 24 months.
  • Have a diagnosis of primary or secondary progressive multiple sclerosis.

More information

To learn more about this clinical trial, contact Ashley Howard, RN, BSN, at 404-367-1279 or email [email protected].

Purpose of this trial

The purpose of this study is to determine whether an evidence-based exercise program delivered virtually by telephone and computer (“telerehab”) produces the same benefits for improving walking and mobility, participation, and quality of life in people with multiple sclerosis when compared to delivery of the program in an exercise facility.

Recruitment for this study is now closed.

More information

To learn more about this clinical trial, contact Erica Sutton at 404-367-1305 or email [email protected].

A healthcare professional in light blue scrubs and purple gloves administers an IV to an older woman sitting in a chair. The woman, wearing glasses and a T-shirt with an Alaska design, smiles and looks at the healthcare professional.

Cutting-edge MS clinical trials

Our Multiple Sclerosis Institute leads clinical trials exploring innovative therapies, including investigational medications, new cell therapies, and advanced medical devices. Lead by Ismari Clesson, our clinical research team oversees 12 ongoing trials, ensuring they meet the highest standards of scientific rigor and participant welfare.

Our MS research team

Shepherd Center’s unique multiple sclerosis research program integrates clinical and research endeavors. This team, led by Dr. Deborah Backus, consists of physical and occupational therapists, speech therapists, exercise specialists, physicians and collaborators from a variety of fields and institutions. This integrated team endeavors to answer meaningful questions and translate findings into clinical practice.

  • Deborah Backus, PT, Ph.D., FACRM, Vice President of Research and Innovation
  • Brad Willingham, Ph.D., Director of MS Research
  • Erica Sutton, Research Coordinator
  • Julie Stowell, PT, D.P.T., Multiple Sclerosis Research Fellow

MS clinical program team

At Shepherd Center, our interdisciplinary team of MS specialists, including neurologists, nurse practitioners, therapists, and more, provides comprehensive care. With access to specialized clinics and services, we ensure personalized treatment within a supportive and family-like environment.

MS research team of collaborators, past and present

  • STEP for MS trial investigators
  • Kevin McCully, Ph.D., University of Georgia, Augusta, Georgia, USA
  • Laura Rice, Ph.D., MPT, ATP, University of Urbana-Champaign, Illinois, USA
  • Jacob Sosnoff, Ph.D., Associate Dean, Research, School of Health Professions,
  • Kansas University Medical Center
  • Can Do MS
  • iConquerMS
  • Abiodun Akinwuntan, Ph.D., MPH, and Hannes Devos, Ph.D., Georgia Regents University, Georgia, USA
  • Ilse Baert, Ph.D., and Peter Feys, Ph.D., Universiteit Hasselt, Biomedical Research Institute, Belgium
  • James Krause, Ph.D., Medical University of South Carolina, South Carolina, USA

From the Newsroom